|
Kodiak Sciences Inc. (KOD) DCF Valuation
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Kodiak Sciences Inc. (KOD) Bundle
Engineered for accuracy, our (KOD) DCF Calculator empowers you to assess Kodiak Sciences Inc. valuation using actual financial data, offering complete flexibility to modify all key parameters for enhanced projections.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA | -46.4 | -128.9 | -258.3 | -322.8 | -259.0 | .0 | .0 | .0 | .0 | .0 |
EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Depreciation | .9 | 4.2 | 8.7 | 11.0 | 18.3 | .0 | .0 | .0 | .0 | .0 |
Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
EBIT | -47.4 | -133.1 | -267.0 | -333.8 | -277.3 | .0 | .0 | .0 | .0 | .0 |
EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Total Cash | 348.2 | 969.0 | 731.5 | 478.9 | 285.5 | .0 | .0 | .0 | .0 | .0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Accounts Payable | 2.6 | 8.6 | 12.4 | 9.1 | 13.6 | .0 | .0 | .0 | .0 | .0 |
Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Capital Expenditure | -.4 | -7.0 | -63.3 | -47.4 | -41.4 | .0 | .0 | .0 | .0 | .0 |
Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITAT | -46.7 | -133.1 | -267.0 | -333.8 | -277.3 | .0 | .0 | .0 | .0 | .0 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -43.6 | -129.8 | -317.8 | -373.5 | -296.0 | -13.6 | .0 | .0 | .0 | .0 |
WACC, % | 13.63 | 13.64 | 13.64 | 13.64 | 13.64 | 13.64 | 13.64 | 13.64 | 13.64 | 13.64 |
PV UFCF | ||||||||||
SUM PV UFCF | -12.0 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 0 | |||||||||
Terminal Value | 0 | |||||||||
Present Terminal Value | 0 | |||||||||
Enterprise Value | -12 | |||||||||
Net Debt | -204 | |||||||||
Equity Value | 192 | |||||||||
Diluted Shares Outstanding, MM | 52 | |||||||||
Equity Value Per Share | 3.66 |
What You Will Get
- Real Kodiak Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Kodiak Sciences Inc. (KOD).
- Full Customization: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates to fit your analysis.
- Instant Valuation Updates: Automatic recalculations to assess the impact of changes on Kodiak's fair value.
- Versatile Excel Template: Designed for quick edits, scenario testing, and comprehensive projections specific to Kodiak Sciences Inc. (KOD).
- Time-Saving and Accurate: Eliminate the need to build models from scratch while ensuring precision and flexibility in your evaluations.
Key Features
- Comprehensive DCF Calculator: Features both unlevered and levered DCF valuation models tailored for Kodiak Sciences Inc. (KOD).
- WACC Calculator: Includes a pre-configured Weighted Average Cost of Capital sheet with adjustable parameters.
- Customizable Forecast Assumptions: Easily alter growth rates, capital expenditures, and discount rates.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Kodiak Sciences Inc. (KOD).
- Visual Dashboard and Charts: Graphical representations provide a clear summary of essential valuation metrics for straightforward analysis.
How It Functions
- Download the Template: Gain immediate access to the Excel-based KOD DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other parameters.
- Instant Calculations: The model automatically refreshes Kodiak Sciences' intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose This Calculator?
- User-Friendly Interface: Tailored for both novices and seasoned professionals.
- Customizable Inputs: Modify assumptions effortlessly to suit your analysis needs.
- Real-Time Updates: Observe immediate changes to Kodiak Sciences Inc.’s valuation as you tweak inputs.
- Preloaded Data: Comes with Kodiak Sciences Inc.’s actual financial metrics for swift evaluations.
- Relied Upon by Experts: Utilized by investors and analysts for making well-informed choices.
Who Should Use This Product?
- Investors: Accurately assess Kodiak Sciences Inc.’s (KOD) fair value prior to making investment choices.
- CFOs: Utilize a professional-grade DCF model for financial analysis and reporting related to Kodiak Sciences Inc. (KOD).
- Consultants: Easily modify the template for valuation reports tailored to clients interested in Kodiak Sciences Inc. (KOD).
- Entrepreneurs: Acquire insights into financial modeling practices employed by leading biotech firms like Kodiak Sciences Inc. (KOD).
- Educators: Implement it as a teaching resource to illustrate valuation techniques relevant to Kodiak Sciences Inc. (KOD).
What the Template Contains
- Pre-Filled DCF Model: Kodiak Sciences Inc.'s (KOD) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Kodiak Sciences Inc.'s (KOD) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.